Skip to main content
BON
NASDAQ Life Sciences

Bon Natural Life Appoints Controller's Wife as CTO for $1,000/Month Salary

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$1.47
Mkt Cap
$11.941M
52W Low
$1.14
52W High
$15.75
Market data snapshot near publication time

summarizeSummary

Bon Natural Life Ltd. announced the resignation of its Chief Technology Officer and the appointment of Ms. Jing Liu, wife of the company's controller, to the role with a monthly salary of $1,000.


check_boxKey Events

  • Chief Technology Officer Resigns

    Mr. Jianli Liu resigned from his positions as Chief Technology Officer and Chief Scientist, effective March 12, 2026. The company stated there was no known disagreement regarding operations, policies, or practices.

  • Controller's Wife Appointed New CTO

    Ms. Jing Liu, a current director and the wife of the company's controller, Mr. Hu Yongwei, was appointed Chief Technology Officer, effective March 16, 2026.

  • Unusually Low CTO Compensation

    Ms. Liu's employment agreement specifies a monthly salary of approximately $1,000, which is highly unusual for a Chief Technology Officer of a public company.

  • New CTO's Qualifications

    Ms. Liu holds bachelor's, master's, and doctoral degrees in chemical engineering and has extensive academic and research experience, including national patents and published papers.


auto_awesomeAnalysis

Bon Natural Life Ltd. announced a significant change in its executive leadership with the resignation of its Chief Technology Officer and Chief Scientist. The appointment of Ms. Jing Liu, who is both a current director and the wife of the company's controller, as the new CTO raises notable corporate governance questions regarding independence and potential related-party transactions. Furthermore, the disclosed monthly salary of approximately $1,000 for a Chief Technology Officer of a publicly traded company is highly unusual and could signal underlying financial constraints or an unconventional compensation structure that warrants investor scrutiny.

At the time of this filing, BON was trading at $1.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.9M. The 52-week trading range was $1.14 to $15.75. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed BON - Latest Insights

BON
Mar 31, 2026, 9:28 AM EDT
Source: Reuters
Importance Score:
7
BON
Mar 19, 2026, 6:03 AM EDT
Filing Type: 6-K
Importance Score:
8
BON
Feb 17, 2026, 9:00 AM EST
Filing Type: 6-K
Importance Score:
7